Skip to content

A phase II study to evaluate the safety of first-time radical gastrectomy by robotic approach for stomach cancer in an early stage

A phase II study to evaluate the safety of first-time radical gastrectomy by robotic approach for stomach cancer in an early stage - ERSTE-M study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000053317
Enrollment
22
Registered
2024-01-10
Start date
2024-01-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Robotic distal gastrectomy (RDG) with lymph node dissection of D1+ or higher, performed under proctor guidance via dual console by surgeons with limited experience performing gastric cancer surgery

Sponsors

Iwate Prefectural Isawa Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Histologically proven gastric adenocarcinoma by endoscopic biopsy. 2) The diagnosis of clinical T1N0. 3) Not indicated for ESD. 4) Distal or total gastrectomy is required for radical resection, and R0 surgery is feasible. 5) No invasion to duodenum. 6) Aged 20 years old or older. 7) Eastern Cooperative Oncology Group performance status of 0 or 1. 8) Body mass index (BMI) is less than 30. 9) No history of upper abdominal surgery except laparoscopic cholecystectomy. 10) No prior chemotherapy, endocrine therapy and/or radiotherapy for any malignancies. 11) Adequate organ functions defined as; i) WBC of 3,000/mm3 or more ii) Platelet count 100,000/mm3 or more iii) AST and/or ALT of 100 IU/L or less iv) T.Bil of 2.0 mg/dL or less v) Creatinine of 1.5 mg/dL or less 12) Written informed consent.

Exclusion criteria

Exclusion criteria: 1) Synchronous or metachronous (within 5 years) malignancies. 2) During pregnancy, within 28 days postpartum, or during lactation. 3) Severe mental disease. 4) Receiving continuous systemic corticosteroid or immunosuppressant treatment. 5) History of unstable angina pectoris within three weeks or myocardial infarction within six months before registration. 6) Poorly controlled hypertension. 7) Uncontrolled diabetes mellitus. 8) Respiratory disease requiring continuous oxygen administration.

Design outcomes

Primary

MeasureTime frame
Incidence of intra-abdominal infectious complications after gastrectomy

Secondary

MeasureTime frame
1. overall survival, 2. relapse-free survival, 3. completion rate of robotic surgeries, 4. incidence of adverse events

Countries

Japan

Contacts

Public ContactMakoto Hikage

Iwate Prefectural Isawa Hospital Division of Surgery

mhikage@med.tohoku.ac.jp0197-24-4121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026